相关实验视频

Updated: Jan 13, 2026

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

肺上皮质的SARS-CoV-2感染导致RNase-III Drosha的裂变和转移增加;Drosha的损失与病毒复制的减少有关

Michael T Winters¹, Emily S Westemeier-Rice², Travis W Rawson¹

¹Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine, West Virginia University, Morgantown, WV 26506, USA.

|October 29, 2025

概括

微RNA处理酶Drosha对SARS-CoV-2具有独特的抗病毒作用,在感染时改变其表达和局部化. 德罗莎枯竭会影响病毒复制,这表明冠状病毒感染的治疗潜力.

科学领域:

分子生物学分子生物学
病毒学病毒学
遗传学遗传学是一个

背景情况:

由SARS-CoV-2引起的COVID-19对全球健康构成重大威胁,需要对其分子机制进行研究.
小型非编码RNAs (sncRNAs) 是宿主和病毒基因表达的关键调节者,包括抗病毒反应.
微RNA处理酶Drosha具有独立于干扰素的已知非正规抗病毒功能.

研究的目的:

为了调查Drosha在SARS-CoV-2感染中的作用.
探索Drosha的异形表达,细胞局部化,以及在SARS-CoV-2感染期间对病毒点的影响.

主要方法:

定量实时PCR (q/RT-PCR) 是一种方法.
西方斑点分析分析
免疫细胞化学和免疫光测定.
使用的肺上皮细胞 (NuLi-1) 和Drosha淘汰细胞系.

主要成果:

特别是在SARS-CoV-2感染后,观察到Drosha异型表达的明显转变,与其他病毒感染或治疗不同.
在SARS-CoV-2感染后的Drosha细胞局部发生变化的鉴定.
证明Drosha剥离减少了SARS-CoV-2的基因组和亚基因组RNA表达.

结论:

德罗沙对抗SARS-CoV-2的新型,干扰素独立的抗病毒作用.
这些发现提升了对SARS-CoV-2宿主-病原体相互作用的理解.
突出Drosha作为未来人类冠状病毒感染的潜在治疗目标.

关键词:

在 COVID-19 疫情中,在RNase-III Drosha中使用.这就是SARS-CoV-2病毒.冠状病毒冠状病毒的新冠病毒.东道主防御的防御方式这就是miRNA生物生成的原因.病原性机制是一种病原性机制.

更多相关视频

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Author Spotlight: Exploring Cloning Techniques for Full-Length DNA Fragments

Author Spotlight: Exploring Cloning Techniques for Full-Length DNA Fragments

Published on: May 17, 2024

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...